Abstract | OBJECTIVE: We herein examine the role of endogenous miR155 in the development of systemic manifestations in pristane induced lupus. MATERIALS AND METHODS: Systemic lupus in miR155-deficient and wild type mice was induced upon injection of pristane and analyzed after 8 months, PBS-injected mice served as controls. Glomerulonephritis and pneumonitis were quantified using the kidney biopsy score and a newly adapted histomorphometric image analysis system; lung tissue was further analyzed by tissue cytometry. Serum levels of anti-dsDNA, anti- histone and anti- chromatin antibodies were measured by ELISA. Frequencies of B cells, activated and regulatory CD4+ T cells as well as Th1, Th2, Th17 cells were measured by flow cytometry. RT-qPCR was used to measure expression levels of interferon-signature and T-cell subset related as well as miR155-associated genes. RESULTS: After induction of lupus, miR155-deficient mice had significant less pulmonary involvement (perivascular inflammatory area in mm2/mm2 lung area 0.00092±0.00015 vs. 0.0027±0.00075, p = 0.0347) and renal disease (glomerular activity score 1.95±0.19 vs 3±0.26, p = 0.0029) compared to wild types. MiR155-deficient mice had significantly lower serum levels of disease-associated auto- antibodies and decreased frequencies of activated CD4+CD25+ (Foxp3-) cells. Upon restimulation, CD4+ cells showed a less pronounced Th2 and Th17 and a slightly decreased Th1 response in mir155-deficient mice. Pristane-treated wild types showed significantly up-regulated expression of genes related to the INF-signature (MX1, IP10, IRF7, ISG15). CONCLUSIONS: MiR155-deficient mice had less severe organ involvement, lower serum auto-antibody levels, a less prominent T cell response and lower expressions of genes jointly responsible for disease development. Thus, antagonizing miR155 might be a future approach in treating SLE.
|
Authors | Harald Leiss, Wilhelm Salzberger, Barbara Jacobs, Irina Gessl, Nicolas Kozakowski, Stephan Blüml, Antonia Puchner, Attila Kiss, Bruno K Podesser, Josef S Smolen, Georg H Stummvoll |
Journal | PloS one
(PLoS One)
Vol. 12
Issue 7
Pg. e0181015
( 2017)
ISSN: 1932-6203 [Electronic] United States |
PMID | 28719617
(Publication Type: Journal Article)
|
Chemical References |
- Autoantibodies
- MicroRNAs
- Mirn155 microRNA, mouse
- Terpenes
- pristane
- Interferons
|
Topics |
- Animals
- Autoantibodies
(metabolism)
- Gene Expression Regulation
(drug effects, immunology)
- Interferons
(metabolism)
- Kidney
(drug effects, immunology)
- Lung
(drug effects, immunology)
- Lupus Erythematosus, Systemic
(chemically induced, complications)
- Mice
- MicroRNAs
(metabolism)
- Nephritis
(complications, drug therapy, immunology, metabolism)
- Pneumonia
(complications, drug therapy, immunology, metabolism)
- T-Lymphocyte Subsets
(drug effects, immunology)
- Terpenes
(pharmacology)
|